Wen, Shilai, Jingke Zeng, Liting Zhong, Jianmin Ye, and Xiaohuan Lai. “The Efficacy and Adverse Effects of Nivolumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma: Nivolumab and Lenvatinib in the Treatment of HCC”. Cellular and Molecular Biology 68, no. 11 (November 30, 2022): 53–57. Accessed November 24, 2024. https://cellmolbiol.org/index.php/CMB/article/view/4593.